Rockefeller Neuroscience Institute’s Marc Haut discusses Alzheimer’s advances at #HLTH2023
Behind-the-scenes of base editing at Beam Therapeutics
Mizuho’s Salim Syed returns to BiotechTV for Analyst Thursdays
Michal Preminger talks about J&J's collaboration through science in Kendall Square and beyond
William Blair’s Andy Hsieh joins BiotechTV for Analyst Thursdays
Harbinger Health’s Steve Hahn on the science of early cancer Dx after raising a $140M Series B
The head of Novo Nordisk's Bio Innovation Hub on collaborating to modify cardiometabolic diseases
Learning about molecular glues from the CEO of Orionis Biosciences following a recent Genentech deal
An entrepreneur describes launching a cell therapy startup in Houston
Michael Torres talks about TMC Innovation, the biotech ecosystem in Houston, and founding companies
Getting the scoop on Houston’s biotech scene with the CEO of BioHouston
Houston Oncology Summit: MD Anderson experts talk about the latest in breast cancer treatments
Houston Oncology Summit: Oppenheimer analyst Jeff Jones on the growth of radiopharmaceuticals
Houston Oncology Summit: MD Anderson’s Funda Meric-Bernstam on antibody-drug conjugates
Houston Oncology Summit: Oppenheimer analyst Matthew Biegler talks about synthetic lethality
TD Cowen’s Tyler Van Buren joins BiotechTV in New York for Analyst Thursdays
Houston Oncology Summit: Talking KRAS & pan-RAS inhibition with MD Anderson’s Ferdinandos Skoulidis
Houston Oncology Summit: MD Anderson’s VP of industry relations talks about partnering
Houston Oncology Summit: How the Cancer Focus Fund can help small biotechs get into phase 1 studies
Houston Oncology Summit: Talking lung cancer advances with John Heymach
.png){kind=logo}
